Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Buy Ipamorelin (Ipa) UK 5mg | UK Peptide Lab

HomeShopIpamorelin Growth Hormone Secretagogues98%+ 5mg £19.99 Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist pentapeptide. Research has shown it stimulates growth hormone release without significantly affecting cortisol or prolactin, making it one of the most selective GH secretagogues available. Often paired with CJC-1295 in synergistic research. One of the most studied compounds in endocrinology. Supplied as lyophilised powder, third-party tested, lab certificate published on this page. Published research on Ipamorelin is indexed on PubMed. See our full UK buyer's guide for Research Peptides. Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance. 98%+ Purity LAB Certified SAME Day Ship Quantity 1 In Stock Order now · Dispatc

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

HomeShopIpamorelin

Growth Hormone Secretagogues98%+

5mg

£19.99

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist pentapeptide. Research has shown it stimulates growth hormone release without significantly affecting cortisol or prolactin, making it one of the most selective GH secretagogues available. Often paired with CJC-1295 in synergistic research. One of the most studied compounds in endocrinology. Supplied as lyophilised powder, third-party tested, lab certificate published on this page.

Published research on Ipamorelin is indexed on PubMed. See our full UK buyer's guide for Research Peptides.

Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.

98%+

Purity

LAB

Certified

SAME

Day Ship

Quantity

1

In Stock

Order now · Dispatched within 24 hours

Add £25.01 more for free UK delivery

Damaged or lost? Free reshipment guaranteed

Research Use Only

This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.

Certificate of Analysis

Third-party tested

LatestUKPL-367

Purity98.958%MethodHPLC-UV / MSLabChromate AnalyticsTestedNov 2025View Lab Certificate

Test Methodology≥98% spec

IdentityRP-HPLC + ESI-MSPurityUV @ 220nm peak areaQuantityGravimetric vs labelRelease spec≥98% purityRequest Older CoA

Lyophilised Stability

24 months

Sealed at -20°C, light-protected

Reconstituted Stability

Up to 3 months

Stored at 2-8°C after mixing

Cold-Chain Shipping

Always

Dry-cold pack, Royal Mail Tracked 24

Important Notice

All compounds are sold individually and do not include research supplies. Products are provided in lyophilised (powder) form and require proper reconstitution before use in research settings.

Related Products

Product Specifications

CAS Number170851-70-4

Molecular Weight711.86 g/mol

Purity≥98% by HPLC

FormLyophilised powder

Research Overview

Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS). It acts by mimicking the endogenous hormone ghrelin and binding to the growth hormone secretagogue receptor type 1a (GHS-R1a) in the anterior pituitary gland. Ipamorelin is distinguished from other growth hormone releasing peptides (GHRPs) such as GHRP-2 and GHRP-6 by its exceptional selectivity, it stimulates growth hormone release without significantly elevating cortisol, prolactin, or adrenocorticotropic hormone (ACTH) levels. This selectivity makes Ipamorelin the most specific GHS available for endocrine research, minimising confounding hormonal variables in experimental designs. Early clinical research by Novo Nordisk investigated Ipamorelin as a potential treatment for postoperative ileus, examining its effects on gastrointestinal motility in addition to GH secretion. In current research practice, Ipamorelin is frequently studied in combination with CJC-1295 (modified GRF 1-29) for synergistic growth hormone secretion, Ipamorelin acting at the GHS receptor and CJC-1295 acting at the GHRH receptor to produce amplified pulsatile GH release through complementary receptor pathways.

Product Specifications

Laboratory Handling

Store lyophilised vials at -20°C. Reconstituted Ipamorelin should be refrigerated at 2-8°C and used within 4 weeks. Reconstitute with bacteriostatic water. Direct the stream of water down the side of the vial and swirl gently. Handle under aseptic conditions using sterile syringes. Wipe vial stopper with an alcohol swab before each use. Avoid repeated freeze-thaw cycles. Prepare single-use aliquots where possible to maintain peptide integrity.

Frequently Asked Questions

All products supplied for laboratory research use only. Not for human consumption or veterinary use.

© 2026 UK Peptide Lab. A trading name of Oraxis Research Ltd.

Oraxis Research Ltd · Company No. 17157816 · Registered in England & Wales.

Registered office: 71-75 Shelton Street, London, WC2H 9JQ.

Open Banking · Bank Transfer

Connected topics

Follow this recovery question